ftInvstr
SUVEN · Healthcare ₹279.1 +1.75% Mkt Cap ₹7396 Cr
← Search another stock

SUVEN

Healthcare Drug Manufacturers - Specialty & Generic
★ Watchlist ⧉ Add to bucket
₹279.1
+1.75% today · 30d -1.71%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for SUVEN. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-09-30
REVENUE
₹1 Cr
+30.4% YoY
NET PROFIT
₹-107 Cr
OPM
-1313.28%
+304.56pp YoY
EPS
₹-3.77
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-4.1% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
SUVEN—-77.0
SUNPHARMA37.7921.44
DIVISLAB93.121.56
ZYDUSLIFE28.424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
48
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 90
Valuation — —
Growth STEADY 55
Profitability LOW 5
Technicals WEAK 40
Risk MODERATE 50
Key Stats
P/B
12.48
52W HIGH
₹403.35
OFF HIGH
-30.8%
DIV YIELD
0.0%
MKT CAP
₹7396 Cr
◉ Active Signals
MACDNeutral3.3776
RSI(14)Neutral47.29
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold SUVEN and at what entry.

Sign up freeSign in
AI-generated research based on publicly available data and ftInvstr's bias-safe quantitative models. Not investment advice. Past performance does not guarantee future results. Consult a SEBI-registered investment adviser before making any investment decision.